NASDAQ: NUVL
Nuvalent Inc Stock Ownership - Who owns Nuvalent?

Insider buying vs selling

Have Nuvalent Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Darlene NociChief Development Officer2025-10-304,000$27.85
$111.40kBuy
Deborah Ann MillerChief Legal Officer2025-10-30600$100.96
$60.58kSell
Deborah Ann MillerChief Legal Officer2025-10-30500$99.66
$49.83kSell
Deborah Ann MillerChief Legal Officer2025-10-301,273$97.98
$124.73kSell
Deborah Ann MillerChief Legal Officer2025-10-30700$96.65
$67.66kSell
Deborah Ann MillerChief Legal Officer2025-10-3021,800$6.89
$150.20kBuy
Darlene NociChief Development Officer2025-10-3057$98.91
$5.64kSell
Deborah Ann MillerChief Legal Officer2025-10-309,382$104.78
$983.05kSell
Deborah Ann MillerChief Legal Officer2025-10-303,491$103.90
$362.71kSell
Deborah Ann MillerChief Legal Officer2025-10-302,121$102.00
$216.34kSell

1 of 23

NUVL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NUVL insiders and whales buy or sell their stock.

NUVL Shareholders

What type of owners hold Nuvalent Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn25.86%18,646,022$1.83BInsider
Deerfield Management Company LP24.95%17,991,024$1.77BInstitution
Fmr LLC13.83%9,968,846$978.64MInstitution
Paradigm Biocapital Advisors LP7.31%5,269,433$517.30MInstitution
Vanguard Group Inc6.27%4,524,124$444.13MInstitution
Blackrock Inc5.61%4,046,256$397.22MInstitution
Price T Rowe Associates Inc2.49%1,795,373$176.25MInstitution
Janus Henderson Group PLC2.47%1,782,581$175.00MInstitution
Matthew Shair2.20%1,586,366$155.73MInsider
Wellington Management Group LLP2.19%1,576,374$154.75MInstitution

1 of 3

NUVL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NUVL75.12%24.88%Net SellingNet Selling
MRUS90.68%9.32%Net Buying
RYTM87.82%12.18%Net SellingNet Buying
CYTK90.09%9.91%Net SellingNet Selling
HALO77.24%22.76%Net SellingNet Selling

Nuvalent Stock Ownership FAQ

Who owns Nuvalent?

Nuvalent (NASDAQ: NUVL) is owned by 98.88% institutional shareholders, 32.74% Nuvalent insiders, and 0.00% retail investors. James E. Flynn is the largest individual Nuvalent shareholder, owning 18.65M shares representing 25.65% of the company. James E. Flynn's Nuvalent shares are currently valued at $1.85B.

If you're new to stock investing, here's how to buy Nuvalent stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.